NEW YORK, Aug. 9 (GenomeWeb News) - Shares in Ciphergen Biosystems were down 6.11 percent, or $.14, at $2.15 in mid-afternoon trading after the company said it was restructuring its business and laying off 20 percent of its workforce.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.
Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.
HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.
Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.